Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
MilliporeSigma™ Calbiochem™ SRT1720
Click to view available options
Quantity:
10 mg
Description
A cell-permeable quinolinecarboxamide compound that is shown to inhibit the mitochondrial SIRT3 in a substrate AceCS2-competitive ( K i = 0.56μM; K m = 2.44μM), but NAD+-uncompetitive ( K i = 0.34μM; K m = 280μM), manner. Also reported to decrease cellular p53 Lys382 acetylation (Effective conc. = 10μM in U2OS and MEF cultures) and inhibit p300 HAT activity (IC50 = 9μM) in vitro , as well as offer therapeutic benefits in several murine and rodent type 2 diabetes models (100mg/kg/dayl p.o.) in vivo . Whether and how SRT1720 activates SIRT1 activity remains uncertain. Also available as a 25mm solution in DMSO (Cat. No. 530748).

Specifications
Specifications
Color | Yellow |
Description | 97% by HPLC |
CAS | 925434-55-5 |
Molecular Formula | C25H23N7OS |
Formula Weight | 469.6g/mol |
Solubility | DMSO |
Content And Storage | Protect from light |
Form | Solid |
Quantity | 10 mg |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction